Triplefin

Triplefin is now EVERSANA. EVERSANA™ combines leading global life science services into an integrated, independent and intelligent commercialization platform.

[Triplefin @Triplefin]

Thank you for visiting. Triplefin is now EVERSANA. Please connect with us and visit us at https://t.co/A2UulUJI8Q for more information.

[Triplefin @Triplefin]

High costs are known to be a major factor in patients abandoning their medications at the pharmacy. For this reason, coupon and voucher programs are especially valuable for patients who face the high cost of therapies required to treat chronic conditions. https://t.co/puVLlK1V9g

[Triplefin @Triplefin]

Meeting patient expectations for a seamlessly connected experience with drug therapy is a competitive necessity for today’s biopharmaceutical enterprise. https://t.co/aA6PWT4ESw

[Triplefin @Triplefin]

As drug therapies become increasingly more complex and expensive, there is a need to help patients who cannot afford vital medications. https://t.co/SX3s4rhA05

[Triplefin @Triplefin]

Exciting news for our life sciences platform! We are now EVERSANA. Read the press release to learn more. https://t.co/KVyTDM695B

[Triplefin @Triplefin]

Inherently scalable, a field reimbursement program provides a mix of virtual, phone-based and in-person support, according to the evolving needs of the brand. https://t.co/tU6LBQE9o2

[Triplefin @Triplefin]

By harnessing digital solutions, manufacturers can craft comprehensive tools that make the treatment experience simpler for the patient and more manageable for the provider to administer - even when dual reimbursement is involved. https://t.co/K2BO7h4YDu

[Triplefin @Triplefin]

Life sciences companies have always been in the business of helping patients, but now they have become responsible for catering to patients' needs in more ways than just providing treatment options. https://t.co/flqcZdFQu0

[Triplefin @Triplefin]

Once the exclusive province of high-cost specialty drugs, hub services are now a key differentiating feature for lower cost, middle tier, and many retail-distributed brands that require the same patient support. https://t.co/D4StpqgCvJ

[Triplefin @Triplefin]

The use of behavior-based coaching strategies aims to inform and motivate patients to close the adherence gap by addressing many of the most common barriers patients face when managing chronic healthcare conditions. https://t.co/IN3Ol0Z7yQ

[Triplefin @Triplefin]

As the need for patient support continues to grow, there is a strong focus on the development of new tools to streamline the PAP process and improve patient access to critical medications. https://t.co/SX3s4rhA05

[Triplefin @Triplefin]

Field Reimbursement Managers are able to help remove barriers to patient access by educating providers on local and regional payer issues, coding changes, and appropriate claim submission. https://t.co/flqcZdFQu0

[Triplefin @Triplefin]

Patients bring a heightened awareness of cost sharing to their decision making, and hub services can play a key role in facilitating co-pay information, first start tools, and patient assistance programs at this early stage of access. https://t.co/D4StpqgCvJ

[Triplefin @Triplefin]

In the battle to differentiate a drug from others in the same therapeutic class, it’s keeping that incisive edge around services delivery that counts. https://t.co/aA6PWT4ESw

[Triplefin @Triplefin]

The next-generation of PAP solutions must consider having a patient-driven website that supports real-time enrollment, provides automation that a supplier can access internally, and initiates outreach to healthcare providers with minimal intervention. https://t.co/bJw2Th0Uwd

[Triplefin @Triplefin]

When patients receive customized coaching to encourage therapy behavior modification, management of chronic conditions improves, and patients are able to conquer common challenges that hinder drug adherence. https://t.co/IN3Ol0Z7yQ

[Triplefin @Triplefin]

Programs that provide access to real-time information and, in some cases, are integrated into the physician workflow are reducing barriers to access for patients with insurance. https://t.co/SX3s4rhA05

[Triplefin @Triplefin]

Rigorous Prior Authorization requirements and complex enrollment and claims forms create numerous hurdles for prescribers. Today’s brand teams are taking a more proactive role in helping prescribers and patients overcome reimbursement-related obstacles. https://t.co/tU6LBQE9o2

[Triplefin @Triplefin]

While advances in medical technology, the growth of oral formulations, and personalized medicine are causes for optimism, manufacturers need to address the very real market pressures in payer coverage models. https://t.co/K2BO7h4YDu

[Triplefin @Triplefin]

By providing analysis, education, training, and troubleshooting, specialized reimbursement experts can help prescribers overcome complex administrative challenges, reduce coverage denials, and speed patient access to therapy. https://t.co/tU6LBQE9o2